Lupin launches asthma drug delivery device in US
The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.
Feb 18, 2015, 17:54 PM IST
Lupin ties up with Poland-based firm for generic asthama drug
Drug major Lupin has inked a pact with Poland-based Celon Pharma to jointly develop and market a generic version GlaxoSmithKline's Advair Diskus, a drug used to treat asthama, in global markets.
Feb 17, 2015, 15:54 PM IST
Lupin gets USFDA approval for diarrhoea drug
"Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly," it added.
Feb 02, 2015, 15:42 PM IST
Govt allows Lupin to hike FII limit cap to 49%
The government Wednesday allowed drug maker Lupin to raise the cap of foreign institutional investor holding to 49 percent, a move that would facilitate an inflow of Rs 6,099 crore.
Jan 28, 2015, 21:08 PM IST
Lupin gets USFDA approval for HIV drug
Drug major Lupin has received US health regulator's approval to market a generic version of ViiV Healthcare's Epivir Tablets, used in treating HIV infection, in the American market.
Dec 26, 2014, 16:04 PM IST
Scouting for acquisitions in India: Lupin
Homegrown drug major Lupin is looking to acquire companies and launch new products in the domestic market as it aims to scale up its Indian operations.
Dec 14, 2014, 14:53 PM IST
Lupin gets USFDA nod for arthritis drug
Drug firm Lupin Tuesday said it has received approval from the US health regulator to market generic version of GD Searle LLC's Celebrex capsules, used to treat arthritis, in the American market.
Nov 03, 2014, 17:18 PM IST
Lupin Q2 net profit up 55% at Rs 630 crore
Drug major Lupin Tuesday posted 55.11 percent rise in its consolidated net profit at Rs 630.04 crore for the second quarter ended September 30, driven by robust sales in the US, Japan and domestic market.
Oct 28, 2014, 15:04 PM IST
Lupin inks pact with Merck Serono to expand in emerging market
Drug major Lupin has entered into long-term partnership with Merck Serono, the biopharmaceutical division of Merck, for expansion in emerging markets.
Sep 16, 2014, 17:02 PM IST
Lupin, Salix sign distribution agreement for Canadian market
Salix will supply the products to Lupin under separate supply agreements.
Sep 12, 2014, 17:46 PM IST
Lupin to market diabetic drug with Korean company
Lupin said it would be responsible for marketing and sales of Basugine in India.
Aug 06, 2014, 19:34 PM IST
Lupin gets ASTD's BEST award for learning & development
Drug major Lupin has received the prestigious American Society for Training and Development's 'BEST Award' for learning and development for 2014.
Jul 16, 2014, 15:48 PM IST
Lupin to set up two new R&D centres in US
The company had also increased research and development spending to Rs 958.28 crore in FY'14 as compared to Rs 770.85 crore in the FY'13.
Jul 06, 2014, 11:41 AM IST
Lupin launches generic Ciprofloxacin in US market
The company had earlier received final approval for the product from the USFDA.
Jun 13, 2014, 17:17 PM IST
